28 7
Top SEO sites provided "28 7" keyword
Keyword Suggestion
Related websites
About Us - 28-7
WEBAbout Us -COMMITMENT TO BUILDING A GREAT TEAM. Our leadership understands the courage needed to commit to the tough journey of drug discovery. As experienced and dedicated explorers, we understand the trust, respect, and teamwork needed to …
Twentyeight-seven.com28-7 Therapeutics raises $65M for cancer drugs aimed at tumor
WEBSep 6, 2018 — Twentyeight-Seven Therapeutics has launched with $65 million in venture capital to fund its treatments for a variety of cancers, which aim to modulate noncoding strands of microRNA to increase the levels of tumor-suppressing genes.
Twentyeight-seven.comCareers - 28-7
WEBWe seek passionate researchers, who are as excited as we are about treating serious diseases with first-in-class compounds. If you are an expert scientist in RNA and/or cancer biology, or on your way to become one, we are interested in hearing from you!
Twentyeight-seven.comNews - 28-7
WEBSep 12, 2018 — 28-7 named by Biospace to NextGen Bio “Class of 2020” Recognized for its pioneering approach to RNA modulators, 28-7 is nominated by Biospace as one of the most exciting newly founded biotechs. READ MORE
Twentyeight-seven.comScience - 28-7
WEBScience -ILLUMINATING NEW PATHWAYS IN SERIOUS DISEASES. Recent science has cast a new light on understanding specific enzymes that are involved in the dysregulation of nucleic acid processing and sensing, and therefore contribute to the development and maintenance of serious diseases.
Twentyeight-seven.comContact - 28-7 - twentyeight-seven.com
WEB490 Arsenal Way, Suite 100B Watertown, MA 02472 Phone: (617) 603 6060.
Twentyeight-seven.comHome - 28-7 28-7 [www.twentyeight-seven.com]
WEBWe are explorers leading the revolution in RNA drug discovery to develop an entirely new class of therapies. We are identifying the chemical motifs to potently and selectively modulate RNA regulatory networks to treat the most challenging diseases.
Twentyeight-seven.comBoston-Harvard Spinout 28-7 Launches with $65M for MicroRNA …
WEBSep 7, 2018 — New cancer biotech 28-7 Therapeutics, a Harvard spinout, is researching an approach that targets cellular fragments that play key roles in cancer growth, and it now has $65 million in funding to advance its work.
Twentyeight-seven.comMPM, Novartis lead a big launch round for Kazumi Shiosaki’s
WEBSep 7, 2018 — And now they have stitched together an impressive $65 million round to take the next preclinical step toward making it a drug at 28-7 — as well as a showpiece for the platform work that’s being planned around it.
Twentyeight-seven.comPrivacy - 28-7
WEBIf you have any questions about this privacy statement, the practices of our Website, or your dealings with our Website, please contact us at the following address or email us at [email protected]. Twentyeight-Seven, Inc. 490 Arsenal Way, Suite 100B. Watertown, MA 02472 (617) 603-6060
Twentyeight-seven.com